Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: Comparative analysis with a fluvastatin-cholestyramine combination

This publication has 17 references indexed in Scilit:

• Tolerability and efficacy of combination therapy with simvastatin plus gemfibrozil in type IIb refractory familial combined hyperlipidemia
  Current Therapeutic Research, 1993
• Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia
  The American Journal of Medicine, 1993
• Addition of fibrates to simvastatin therapy in hyperlipidaemic patients
  Atherosclerosis, 1992
• Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias
  The American Journal of Cardiology, 1992
• Effects of Combined Bezafibrate-Simvastatin Appraised in Healthy Subjects
  The Journal of Clinical Pharmacology, 1992
• The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia
  Metabolism, 1990
• Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
  Circulation, 1989
• Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
  Circulation, 1989
• More on Rifampin Prophylaxis againstHaemophilus influenzaeb in Day-Care Facilities
  New England Journal of Medicine, 1988
• Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides
  Metabolism, 1982